Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Value Trial Group

Research output: Contribution to journalArticleScientificpeer-review

169 Citations (Scopus)
Original languageEnglish
Pages (from-to)403-411
JournalJOURNAL OF HYPERTENSION
Volume26
Issue number3
Publication statusPublished - 2008
Publication typeA1 Journal article-refereed

Cite this